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Oligonucleotide-based label-free detection with
optical microresonators: strategies and challenges
Pelin Toren,ab Erol Ozgurab and Mehmet Bayindir*abc
This review targets diversified oligonucleotide-based biodetection techniques, focusing on the use of
microresonators of whispering gallery mode (WGM) type as optical biosensors mostly integrated with lab-
on-a-chip systems. On-chip and microfluidics combined devices along with optical microresonators pro-
vide rapid, robust, reproducible and multiplexed biodetection abilities in considerably small volumes. We
present a detailed overview of the studies conducted so far, including biodetection of various oligonucleo-
tide biomarkers as well as deoxyribonucleic acids (DNAs), ribonucleic acids (RNAs) and proteins. We partic-
ularly advert to chemical surface modifications for specific and selective biosensing.
1. Introduction
Biosensing covers all the analytical methods used to detect
the presence of biological entities within a medium and the
interactions among them, using various equipment and
methodologies. Besides its indispensable everyday applica-
tions, biosensing is also a prominent research field since
there is a huge demand for label-free, ultra-sensitive, scaled
down and robust biosensors in basic research as well as in
the food, environmental, biomedical, and pharmaceutical
technologies. For this purpose, during the past decade, a
significant number of methods with novel alternative
strategies1–3 have been suggested.
Biosensors are analytical devices specialised for detection
of a certain biological species. Similar to signal transduction
pathways in cellular biology, biosensors consist of two basic
parts, which are receptor and transducer. The receptor recog-
nises the target, while the transducer converts the receptor–
target interaction into a measurable signal. In biosensors,
several transduction mechanisms exist, which can be
categorised under main titles including mechanical,4 acous-
tic,5 electrical6 and optical.7
Optical sensors, among the most investigated biosensing
tools, particularly provide opportunities for label-free, highly
sensitive sensing capabilities with small working volumes,
easy on-chip integrations, and fast and multiple read-outs.
They are also quite suitable platforms for investigating light–
matter interactions. Since such interactions can be mathe-
matically described using two parameters, refractive index (n)
and extinction coefficient (k), these parameters also define
the characteristics of materials in terms of optical properties.
Therefore, a considerable amount of research has been de-
voted to deciphering and engineering the optical characteris-
tics of materials. One of the important branches, which
sprouted out of optical engineering, is detecting the presence
of various interactions between materials by exploiting the
changes in the measured optical characteristics.8 Among dif-
ferent applications of optical detectors, one of the most prac-
tical applications is biological sensing, where optics provides
invaluable opportunities.9
Most biological entities and biological interactions occur
within the nanometer scale. This makes their direct visualisa-
tion impossible without causing them serious harm. Labelling
biological samples with fluorophores is a limited solution
with several issues to consider such as adverse interaction of
the label with the sample and difficulty in real-time observa-
tion.10 Therefore, label-free biosensors enabling detection of
biological materials and their interactions are essential for a
better comprehension of all biological phenomena. There are
various methods for label-free biodetection,11,12 all employing
indirect methods for realising their purpose. Electrochemical
sensors,13 for instance, can measure a change in electrical im-
pedance, conductivity or electric potential caused by the inter-
action of an analyte with the biosensor. Optical biosensors,
on the other hand, provide this information by taking into ac-
count the changes in n and k using various strategies. Differ-
ent types of biosensors possess distinct comparative advan-
tages and deficiencies. These criteria directly influence their
applicability over various biosensing issues. The most impor-
tant characteristics determining the applicability of a biosen-
sor are sensitivity, selectivity, dynamic range, robustness, and
2572 | Lab Chip, 2016, 16, 2572–2595 This journal is © The Royal Society of Chemistry 2016
a Institute of Materials Science and Nanotechnology, Bilkent University, 06800
Ankara, Turkey. E-mail: bayindir@nano.org.tr; Tel: +90 312 290 3500
bUNAM-National Nanotechnology Research Center, Bilkent University, 06800
Ankara, Turkey











































View Journal  | View Issue
Lab Chip, 2016, 16, 2572–2595 | 2573This journal is © The Royal Society of Chemistry 2016
cost. These parameters are all intertwined, imposing strict
compromises among each other.
Optical biosensors, compared to their mainstream bio-
chemical or electrochemical counterparts such as Enzyme-
Linked Immunosorbent Assay (ELISA)14 or blood glucose
sensors,15 have a limited use in biosensing, particularly due to
their generally complex operation and relatively higher perfor-
mance and maintenance cost. On the other hand, there are
certain potentials yet to be realised, motivating researchers to
devote considerable effort in order to devise novel optical bio-
sensors. The main reasons for pursuing optical sensors for the
detection of biomolecular species and interactions are the pos-
sibility of ultimate, i.e. single entity, detection,16 the potential
of fabrication from well-defined materials,17 and the maturity
in methods for appropriate functionalisation of particularly
silicon-based optical biodetection.18
Among various methods of optical biosensing, resonators
of whispering gallery mode (WGM) type solely have the po-
tential for ultimate sensitivity.16 The WGMs were first ob-
served in the inner walls of a cathedral with a circular struc-
ture, which allows sound waves to travel at certain
frequencies through the inner circumference. Later on, a sim-
ilar phenomenon was discovered in micro-optical structures,
in which the light waves travel through a circular path due to
total internal reflection.16 In such structures, the resonant
modes exist only at discrete multiples of wavelengths which
are determined by the length of the resonators (mλ = Ln).19
When an analyte is adsorbed on the microresonator surface,
the path length of the light inside the microresonator is al-
tered, causing a shift in the resonant wavelength, which is
tracked for sensing and quantifying biological species.20
The figure of merit of these WGM microresonators is the
quality (Q) factor, which is the ratio of the total optical power
accumulated within the microresonator to the power dissi-
pated with various mechanisms such as absorption, scatter-
ing or coupling.21 The higher the Q factor of a micro-
resonator, the sharper the resonant mode becomes due to
the fact that the time each photon travels within the micro-
resonator also increases while the circumference remains
constant; thus, more strict measures apply for a photon to
satisfy the resonance condition in terms of wavelength.21
This positively affects the WGM biosensors in terms of sensi-
tivity in two aspects, sharper resonances, which provide eas-
ier WGM shift tracking, and longer photon–analyte interac-
tion times, thus increasing the efficiency. The latter one
leads to one of the critical advantages of WGM biosensing,
paving the way for single biological entity detection.21 The
only alternative to this strategy is reducing the mode volume,
i.e. the volume in which light is confined drastically, such as
in the case of plasmonic nanoparticles, where even alter-
ations caused by single molecules become detectable.22 Yet,
compared to WGM biosensors, this is a relatively recent tech-
nology requiring a specialised set-up for dark-field imaging
with high sensitivity. WGM microresonators have been re-
cently demonstrated to be even capable of single molecule
detection by exploiting the plasmonic enhancement.23
WGM biosensors form a suitable platform for bio-
detection in which light interacts with the analyte in the vi-
cinity of the microresonator. In order to perform bio-
sensing, light must be coupled to the microcavity during its
travel. The most efficient method for coupling light by satis-
fying resonance conditions and observing a shift in the
tracked resonance mode simultaneously is using a tuneable
laser with a narrow linewidth. External cavity lasers24 or dis-
tributed feedback lasers25 are generally used for this pur-
pose. Current laser systems provide tuneability with sub-
picometer resolution. A significant part of biodetection
using WGM microresonators is the detection of the optical
signal. On this side, blind photodetectors connected to a
power meter or directly to an oscilloscope could be effec-
tively used.26 The rest of the measurement is basically sig-
nal acquisition and processing, where an oscilloscope and a
computer are required. A schematic description of WGM
biosensing is given in Fig. 1.
WGM biosensors are mostly fabricated using standard
micro-processing materials, i.e. silicon and silicon dioxide,
via various microfabrication techniques. For producing some
of the types including microtoroids, a post-fabrication pro-
cess is required, in which surface roughness is significantly
decreased by thermal treatment, resulting in ultrahigh Q
microresonators, where energy dissipation primarily occurs
due to optical absorption of the material from which the res-
onator is produced. These microcavities are referred to as
surface tension induced microcavities (STIMs).27 They have
quite low surface roughness values, reducing scattering losses
virtually down to zero. On the other hand, it is extremely
cumbersome, if not impossible, to provide a robust on-chip
waveguide integration with the STIM microresonators, except
for some rare examples.28 The light is commonly coupled to
the STIMs either via tapered fibres or via prism couplers.
However, these light coupling approaches require precise
alignment and are inconvenient to integrate with micro-
fluidic systems, particularly for the tapered fibre coupling.
Non-STIM microcavities, on the other hand, can be fabricated
with on-chip waveguides. However, they have at least 2 orders
of magnitude lower Q values, preventing their use in single
molecule biodetection.21 Nevertheless, the non-STIM micro-
resonators, particularly microrings, are significantly advanta-
geous especially in multiplexed detection because tens of
microrings can be fabricated and utilised in a parallel man-
ner, and this is unique to the microring resonators.
Biosensing heavily depends on the sensitive and selective
target detection capability of the biosensor. For this issue,
the approach used in surface modification for conjugating
probe molecules is crucial. In order to perform feasible bio-
sensing, the surface of the biosensor should be engineered
elaborately. Entities for molecular recognition, which are gen-
erally referred to as probe molecules, are a must for bio-
detection. The first prerequisite of the surface modification is
covalent or non-covalent attachment of the probe molecules
onto the biosensor surface. However, many parameters
should be individually considered besides probe conjugation
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for an enhanced sensitive and selective biodetection. The ap-
proach used in probe conjugation can be considered ade-
quate for a reliable biosensing to some extent; however, for
most cases, additional surface chemistry is required, espe-
cially for biosensing in a complex medium.26 A myriad of dif-
ferent strategies exist for biosensor surface modification,
where different problems demand different solutions.18 Yet,
some of these solutions are inevitably more effective than
those of their counterparts in terms of efficiency and reliabil-
ity. Here, it is important to mention that silane-based surface
modification is dominant in optical biosensors, since silane
molecules enable covalent attachment on silicon/silica-based
surfaces, which constitute the vast majority of the WGM bio-
sensors. On the surface of a WGM biosensor, various func-
tional groups can be obtained using silane chemistry. Each
functional group provides a distinct characteristic to the bio-
sensing system, while the strategy follows a common pattern
based on silane chemistry, as illustrated in Fig. 2.18 Adverting
to surface modification strategies used in WGM biosensing is
among the goals of this review.
Biomolecular interactions (such as antibody–antigen) oc-
cur within an aqueous medium. This fact compromises the
use of the WGM type of microcavities regarding several as-
pects. The first issue that needs to be considered is the wave-
length to be used. Although the optimum wavelengths in sil-
ica structures are 1310 and 1550 nm, which are also referred
to as telecom wavelengths for the minimum loss of silica, at
these wavelengths there is considerable water absorption.29
Therefore, visible and near-infrared wavelengths, such as 670
nm, are shown to be more effective in optical biosensing.29
Also, another important concern is optical coupling in aque-
ous media. Especially, tapered fibre coupling suffers heavily
Fig. 1 Schematic diagram summarising the oligonucleotide-based biosensing approaches using various optical resonators (microtoroids,
optofluidic ring resonators (OFRRs), microrings and microspheres). Light incoming from a continuously sweeping laser source is coupled to an op-
tical resonator via a tapered fibre, an on-chip waveguide or a prism coupler. The intensity of the transmitted light is traced using a detection sys-
tem. The resonance wavelength shift (from λ1 to λ2) of the traced WGM is analysed. The biosensing module, in which coupling and analyte infusion
through the surface modified resonator occur, can be either a microfluidic or a flow system.
Fig. 2 Surface modification of an optical resonator for specific target
detection. The schematic drawing shows a general approach to the
chemical modification of a silicon/silica-based optical resonator for
specific oligonucleotide-based detection. (1) Cleaning of biosensor via
UV/ozone or chemical treatment to induce the formation of reactive
silanol groups. (2) Pre-functionalisation of the biosensor surface with a
silane molecule via silane condensation reaction, where OR′ can be a
methoxy, ethoxy or acetoxy group and X can be an alkyl, aryl or
organofunctional group. (3) Surface functionalisation by covalently
conjugating an oligonucleotide probe (either modified or non-modi-
fied) to the silane-coated biosensor. Additionally, in between a silane
molecule and a probe, a linker molecule can be used. (4) Specific tar-
get detection using probe–target interactions.
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from mechanical perturbations occurring within the environ-
ment,30 particularly by the presence of a fluid flow.
Microfluidic integration with the WGM biosensor in-
creases the biosensing efficiency substantially. Yet, not all
the optical biosensors, especially the high-Q ones, are com-
patible with microfluidic systems, mainly due to limitations
in optical coupling. Microfluidic integration, on the other
hand, provides invaluable efficiency and flexibility, especially
in multiplexed detection. It would be fair to indicate that
there is a trade-off between the sensitivity and the micro-
fluidic compatibility of WGM biosensors, despite many seri-
ous efforts to overcome this challenge. For microresonators
having a high-Q factor, an idealised multiplexed optical bio-
sensing system with microfluidic integration is shown in
Fig. 3.
The goal of this review is to discuss biodetection of/with
oligonucleotides in detail. Oligonucleotide-based detection is
a critical issue, since oligonucleotides possess the informa-
tion regarding the origin and nature of life. Therefore, detec-
tion of oligonucleotides with high sensitivity and selectivity is
an important issue accordingly. Among many different
methods for oligonucleotide detection, quantification and
analysis, optical biosensors are promising tools; yet, from our
point of view, it is still far from realising their full potential.
Our aim for writing this review is therefore first critically
analysing the current status of optical biosensing using par-
ticularly the WGM microresonators and then describing the
pros and cons of each different approach within this broad
set objectively. Finally, we would like to comment on the fu-
ture direction of oligonucleotide-based optical biosensing.
Also, significant attention to the surface chemistry used in
WGM biosensors is required to understand specific molecu-
lar interactions.
This review is divided into three main sections according
to target types (DNA, RNA and protein). Also, a comprehen-
sive summary of different oligonucleotide detection strategies
with their experimental results is given in Table 1. As can be
seen from Table 1, there are already quite successful results
in terms of sensitive and selective optical biodetection using
oligonucleotides. Surface modification strategies using the
WGM type of biosensors are considerably mature and serious
progress has been made through optical coupling and micro-
fluidic integration of these optical microstructures. Our pri-
mary aim is to explain the critical steps towards these accom-
plishments while writing this review.
2. Detection of deoxyribonucleic acid
(DNA)
2.1 DNA hybridisation and distinguishing single mismatches
Since the identification of the structure of DNA55 in 1953, at
an increasing pace we are learning more about it. DNA mole-
cules perform two important tasks: they replicate themselves
by making copies of themselves from the beginning of life and
they indirectly supervise the protein expression.56 Thus, unsur-
prisingly, there is a tight relationship between various disease
states and DNA alterations.35 Understanding and detecting
disease-related variations in DNA molecules are essential in
early detection, which increases our chance of living.
There has been a tremendous effort to develop sensitive
and sequence-specific DNA sensing platforms until now.
Throughout the years, several DNA biosensing approaches
have been developed, such as Polymerase Chain Reaction
(PCR),57 DNA arrays,58,59 nanomechanical DNA sensors,60
electrochemical DNA sensors,61,62 and DNA biosensors based
on graphene,63 surface plasmon resonance,64 nano-fibre65
and nanowire.66 Here, we introduce, DNA sensing approaches
using optical microresonators.
It would be beneficial to begin with a former work of
Vollmer F. and co-workers31 in which multiplexed quantifica-
tion of DNA was done using two silica microspheres. In order
to hybridise with their fully complementary targets, individu-
ally, 27-mer oligonucleotides of interest were conjugated to
dual microspheres via streptavidin–biotin interactions. By
evanescently coupling light from a tuneable laser source to
dual microspheres in a liquid sample cell, the resonances
from each microsphere were identified separately in the
transmission spectra as individual Lorentzian dips. In order
to demonstrate the ability of the suggested biosensing plat-
form in terms of distinguishing single mismatch alterations,
Fig. 3 Multiplexed oligonucleotide-based detection using micro-
toroids as optical resonators having high-Q factors. Illustration of a
lab-on-a-chip biosensing system consisting of microfluidic channels
each having one microtoroid (yellow circles), which can be used for
multiplexed oligonucleotide-based detection. The proposed system
has four inlets (from I1 to I4) and one outlet for controlled target flow
in small volumes. Data are gathered separately from optical outputs,
which are all branched from a common optical input (red lines). The
inset shows an on-chip, curved waveguide and a microtoroid located
at a critical distance as a schematic drawing regarding a previous
work.28
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hybridisation between match and mismatch of an 11-mer oli-
gonucleotide was shown. Also, the mismatch detection ability
of the biosensor platform was demonstrated at an optimised
specific temperature (∼23 °C) and optimized salt concentra-
tion (20 mM tris, 30 mM sodium chloride at pH 7.8). The
sensitivity of the suggested technique was reported as 6 pg
mm−2 mass loading. The authors of the article provided in-
formation about the sensitivity of their biosensor only in
terms of the mass loading, while the minimum detection ca-
pability according to the analyte concentration was not given.
A work of Wu Y. and co-workers32 can be given as an ex-
ample of the high specificity and sensitivity of DNA detection
as an alternative approach besides its reusability and versatil-
ity. DNA loading and unloading from a microsphere (Fig. 4a)
was provided via a DNA catalytic network scheme with a LOD
of 22-mer DNA oligonucleotide of ∼80 pM (32 fmol). Since
the suggested idea was based on analyte unloading from the
microresonator, a reusable DNA biosensor was obtained
using this technology.
Probe DNA molecules, which could be used to detect mul-
tiple analytes, were attached to the microsphere surface via
biotin–streptavidin interactions (Fig. 4b, P molecule) as in
the previous study.31 The DNA unloading from the surface oc-
curred via a catalytic reaction (Fig. 4b, S and B leaves the sur-
face). Fig. 4c shows the optical transmission spectra of the
DNA unloading from the microsphere causing a blue shift.
Single base alterations were reported, which were detected
via the DNA loading/unloading rates by a factor of 40 to 100.
On the other hand, microrings as another branch of opti-
cal resonators are also opportune tools for DNA bio-
sensing33,67 and identifying the point mismatches33,37,39 by
providing high-throughput and real-time analyses with on-
chip integrations as in arrays. In a work of A. J. Qavi and co-
workers,33 an isothermal approach to discriminate single nu-
cleotide polymorphisms (SNPs) was demonstrated. 32 silicon
microrings (30 μm in diameter) consisting of reference
microrings for thermal drifts on a sensor array were assem-
bled into a flow channel. N-Succinimidyl-4-formylbenzamide
(S-4FB) modified ssDNA strands were covalently conjugated
to HyNic silane functionalised microrings. Multiplexed DNA
detection was provided by hand-spotting four different ssDNA
probes having solutions complementary to 4 different target
ssDNAs on a sensor array. Detection of the single base alter-
ations was done by monitoring the desorption rates of the
target ssDNAs leaving the formed DNA duplexes on the bio-
sensor surface, similar to an approach demonstrated in the
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aforementioned study32 (Fig. 5a and b). The target binding
kinetics due to either hybridising with fully complementary
counterparts or targets having SNPs at different positions af-
fected the desorption rates, resulting in different blue WGM
shifts (Fig. 5c). The LOD for this study was reported as 195
fmol (1.95 nM) target DNA.
Nevertheless, single base pair alterations can also be ob-
served using different approaches such as engineering the
surface of the optical microresonators. Recently, we have
demonstrated34 how an optical microresonator with an
engineered surface could be able to detect single base pair
variations in a DNA molecule. Since detecting even point mis-
matches in the DNA molecule plays a vital role in DNA bio-
sensors31 in terms of enhancing the biosensor performance
for distinguishing alterations, the suggested approach pro-
vided a considerably high selectivity for DNA biosensing.
Fig. 6a shows the SEM image of the fabricated microtoroid
(∼110 μm in diameter). The scheme for the surface engineer-
ing is shown step by step in Fig. 6b. For a selective single
base pair DNA detection, the APTES and TMMS
functionalised silica microtoroid surface was modified to ob-
tain NHS esters via amine groups of the APTES molecules.
While the amine groups were sequentially converted to car-
boxylates and NHS esters, the TMMS molecules remained the
same on the surface and served as spacers to avoid steric ef-
fects which decrease the efficiency of the DNA
hybridisation.68,69 Covalent conjugation of the amino-
modified ssDNA probes (Fig. 6b, red coils) was achieved via
NHS-esters and the residual NHS esters were capped using
ethanolamine, which resulted in a negatively charged micro-
toroid surface. Fig. 6c shows resonance wavelength shifts due
to fully complementary (red data), point mismatched (blue
data) and non-complementary ssDNA strands (grey data) of a
13-mer ssDNA probe in real time. Considerably late and slow
responses were obtained from the point mismatch DNA and
probe–DNA interactions as compared to the shifts (pm) ob-
served in the complementary and probe–DNA interactions.
Due to the fact that the surface had a negative overall charge,
the repulsive forces occurring on the surface provided a high se-
lectivity in terms of discriminating the single point alterations
in Pseudomonas aeruginosa related oligonucleotide sequences.
The LOD and surface coverage ratio of the captured targets to
the attached probes were 2.32 nM and 0.84, respectively.
As one of the prominent examples of the optical
microresonator-based DNA detection scheme, a work of M.
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presented single nucleic acid detections using plasmonic
nanorods adsorbed on silica microspheres (Fig. 7). Micro-
spheres as optical resonators (Fig. 7a) are promising and sen-
sitive tools for observing DNA–DNA interactions due to their
high Q factors. However, lowering their detection limits down
to single nucleic acids requires integration of the optical
microresonators with plasmonic nanoparticles, which en-
hances the optical field strength at the microresonator sur-
face.23,70 Once the intensity of the surface plasmon resonance
absorption increases, enhancement of the electric field is
obtained. Gold and silver have a mean free path of ∼50 nm,
hence when their sizes are smaller than ∼50 nm, only inter-
actions with the surface are allowed since bulk interactions
are not possible. The surface plasmon resonance condition is
satisfied when the wavelength of light is much larger than
the size of the nanoparticle and it depends on the size, shape
and dielectric constants of the metal and surrounding mate-
rial.71 It was reported in the above-mentioned study23 that
gold nanorod (∼12 nm × 12 nm × 42 nm) was chosen as the
plasmonic nanoparticle because it provided strong field
enhancements.
Thiol-functionalised oligonucleotides as receptors were co-
valently conjugated to CTAB stabilised gold nanorods follow-
ing adsorption of the nanoparticles onto the microresonator
surface. The optical measurements for observing nucleic acid
kinetics were taken in a PDMS cell where target flow and the
microsphere took place (Fig. 7b). The light from a continu-
ously swept tuneable laser (∼780 nm) was coupled to the
microresonator via a prism coupler (Fig. 7b). It is noteworthy
that the prism coupler is thoroughly helpful during the bio-
sensing measurements as compared to the tapered optical fi-
bres. It is important here to note that it is quite possible dur-
ing a biosensing measurement, which is performed using a
tapered fibre, to easily lose the transmission obtained from
the fibre due to adsorption of the molecules in the tapered
region, especially in concentrated measurement buffers. An-
other possibility, which is commonly encountered while
using the tapered fibres, is that the changing coupling dis-
tance between the fibre and the microresonator can easily
result in experimental errors. Such errors, for instance, can
be avoided using UV-curable epoxy droplets by fixing the fi-
bre from two sides.34 However, fixing the fibre without los-
ing the fibre transmission and breaking it is a challenging
task. However, in the case of a prism coupler all these diffi-
culties are avoided.
Fig. 5 Distinguishing the SNPs via real-time kinetic desorption using
arrays of silicon microrings. (a) Schematic drawing showing
hybridisation and dissociation between probe ssDNAs (blue strands)
and complementary ssDNAs (red strands). (b) An observed blue WGM
shift (Δλ) due to the desorption of the targets from the biosensor sur-
face. (c) Hybridisation and desorption responses obtained from the
ssDNA probe having microrings exposed to fully complementary coun-
terparts and targets having SNPs at 3 different positions. Pure buffer
was infused at time = 20 min. Adapted from ref. 33 with permission.
Fig. 4 DNA detection using a label-free microsphere integrated with a
DNA catalytic network. (a) A micrograph of a microsphere (∼300 μm in
diameter), (b) the surface modification approach providing DNA load-
ing/unloading (S and B molecules) with interaction with the DNA probe
(P molecule) attached via biotin–streptavidin interactions, and (c) a blue
WGM shift (Δλ) in the transmission spectra due to the loading and
unloading of the DNA molecules in succession. Adapted from ref. 32
with permission.
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Fig. 7c shows the monitored single DNA–DNA interaction
kinetics in both the TE and the TM spectra simultaneously. A
22-mer oligonucleotide probe, interacting with its 3 base pair
mismatched complementary target on the nanorod surface,
caused resonance wavelength shifts (Δλ) in the fm level as
spikes (Fig. 7c). Additionally, in this study, the detection of
single interactions even down to octamers and small interca-
lating molecules was demonstrated. The suggested technique
is also promising for biosensing applications integrated with
microfluidic systems.
An alternative approach for detecting formed DNA du-
plexes with microresonators was demonstrated in the work of
R. M. Hawk and co-workers.35 In this study, a microtoroid
(Fig. 8a) was functionalised with GPTMS and then amino-
Fig. 7 Monitoring single molecule DNA interactions using a silica
microsphere. (a) Image of a glass microsphere melted from an optical
fibre (79 μm in diameter). (b) Schematic drawing showing
oligonucleotide interactions on a plasmonic nanorod having a
microsphere surface (on the top left corner) and biosensing set-up in
which optical measurements were taken. A tuneable laser, centred at
∼780 nm, was coupled to the microsphere in a polydimethlysiloxane
(PDMS) cell via a prism coupler and transverse electric (TE) and trans-
verse magnetic (TM) spectra were recorded using a polarising beam
splitter (PBS) and photodetectors (PDs). (c) Recorded resonance wave-
length shifts (Δλ) for TE and TM modes, simultaneously, due to interac-
tions of 22-mer oligonucleotide probes with their three base pair
mismatched complementary targets. Adapted from ref. 23 with
permission.
Fig. 8 Real-time and fluorescence detection of DNA hybridisation
using a microtoroid with a functionalised surface. (a) Scanning electron
micrograph of the fabricated microtoroid. (b) The biosensing set-up
shows a fibre coupled spectrograph and a microtoroid. (c) The biosen-
sor response to Cy5-labelled ssDNA targets is shown as a red line
while the black line shows a case without the targets present. (d) The
data show the response of the biosensor to unsuccessful (higher peak)
and successful (lower peak) DNA hybridisations at 670 nm. Adapted
from ref. 35 with permission.
Fig. 6 Real-time and selective detection of single base pair alterations
in the DNA molecules using surface engineered microtoroids. (a)
Scanning Electron Microscopy (SEM) image of a fabricated
microtoroid. (b) Step-by-step surface engineering of the microtoroid
surface: APTES/TMMS silanization (1), succinic anhydride incubation in
dimethylformamide (DMF) (2), EDC/NHS incubation in DMF to form
NHS esters (3), ssDNA conjugation (red coils) to the formed NHS-
esters (4) and capping of the residual NHS esters with ethanolamine
(5). (c) Real-time WGM shifts (pm) due to fully complementary (red
data), point mismatched (blue data) and non-complementary ssDNA
strands (grey data) of the 13-mer ssDNA probe. Scale is 20 μm.
Adapted from ref. 34 with permission.
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modified 20-mer ssDNA probes were covalently conjugated to
the microtoroid surface. The hybridisation between the
probes and their cyanine (Cy5)-labelled counterparts was
detected by a spectrograph (Fig. 8b). Fig. 8c shows the bio-
sensor responses with and without 2 μM Cy5 labelled ssDNA
targets present due to the excitement of the Cy5 fluorophore
by the evanescent field. Fig. 8d shows transient and perma-
nent peaks at 670 nm arising from unsuccessful and success-
ful DNA hybridisations on the surface of the microtoroid, re-
spectively. The study proposed a fluorescence-based DNA
hybridisation technique in real time with detection of the tar-
get ssDNAs down to 1 nM.
Another approach for DNA sensing is through the use of
OFRRs or liquid core optical ring resonators (LCORRs), which
are suitable platforms for sensitive DNA detection and quan-
tification.72 The OFRRs offer ring resonator-based biosensing
combined with microfluidics technology. The principle of the
WGM-based DNA sensing using an OFRR is schematically
shown in Fig. 9. A shift in the WGM mode can be observed
with a refractive index change at near surface as the target
ssDNAs hybridising with their probe counterparts attached
on the inner surface of the OFRR during sample flow.
J. D. Suter and co-workers36 used an OFRR or LCORR
coupled to a tapered fibre (1550 nm) to show the DNA
hybridisation with targets having different target lengths (25–
100 bases) and the biosensor was able to distinguish base
pair mismatches (from 1 to 5). The inner surface of the OFRR
was modified with the 3-APS molecules and, using a homo-
bifunctional linker DNA, amino modified ssDNA probes were
covalently conjugated to the modified inner surface. The
LOD of 25-mer DNA samples was given as 2.7 × 1010 mole-
cules per cm2. The mass loading limit of detection was
reported in the order of 4 pg mm−2, which was closer to the
value obtained in the above study.31
Before concluding this section, we would like to advert to
DNA detection in complex media using optical resonators.
Biodetection in complex media is a challenging task since
undesired non-specific interactions can easily occur between
the biosensor surface and its surrounding medium, which re-
sults in false signals and compromises the selective detection
of target molecules.26 Y. Shin and co-workers37 developed a
biosensing platform consisting of an array of microrings
(with a reference microring for the thermal drifts) for detec-
tion of DNA biomarkers related with bladder cancer in hu-
man urine (mutated fibroblast growth factor receptor 3 and
Harvey RAS genes). The DNA probes modified with an amine
group were covalently attached to the APTES/GAD chemistry
applied microring surfaces. An enhanced signal in the WGM
shift was observed as the probe DNA molecules hybridised
with their biomarker counterparts; however, the WGM shifts,
due to the non-specific interactions between human urine
and the microring surface, could not be eliminated and
resulted in WGM shifts lower than the WGM shifts observed
due to DNA hybridisation. While measuring in complex me-
dia, reducing the spectral shifts arising from non-specific in-
teractions can only be achieved by using multifunctional sur-
face modification, which enables probe conjugation and
protein resistance simultaneously. In recent works,26,73 we
demonstrated a multifunctional surface coating which pro-
vides a selective biodetection of interleukin-2 antigens in
complex media.
2.2 DNA amplification and detection of genetic variations
PCR74 is the most commonly used nucleic acid amplification
technique. However, recombinase polymerase amplification
(RPA) is an alternative method to the PCR, which enables
DNA amplifications at a low and constant temperature (∼37
°C)75,76 contrariwise to the PCR. This isothermal method pro-
vides enzyme-oriented synthesis77 of the DNA molecules.
Also, undesired side products of the PCR, such as primer di-
mers, can be reduced by using the RPA technique.39 In a con-
secutive manner, the RPA process is performed by three en-
zymes: recombinase, ssDNA binding protein and polymerase.
The recombinase forms a complex in between a template
double stranded DNA (dsDNA) and its opposing primer parts
and expedites the strand exchange at cognate sites (Fig. 10,
(1) and (2)). Stabilisation of the structures is done by the
ssDNA binding proteins which prevent branch migration75
(Fig. 10, (3) and (4)). Lastly, DNA elongation is performed by
the strand displacing polymerase to end the RPA process
(Fig. 10, (4) and (5)).
Combining the RPA technique in the solid-phase with an
optical microresonator having a biosensor array is an emerg-
ing field, which enables real-time and specific DNA detection
by providing rapid DNA amplification in a small working vol-
ume. For this purpose, J. S. del Rio and co-workers38 devel-
oped a biosensor platform consisting of arrays of label-free
microrings to perform solid-phase RPA (SP-RPA) of the DNA
molecules.
As shown in Fig. 11a, the fabricated biosensor chip had
8 columns of 4 pairs of microrings. 4 microfluidic channels
having 6 pairs of functionalised and 2 pairs of non-
functionalised microrings as blank controls addressed a total
of 8 pairs on the biosensor chip. Collected light at input opti-
cal couplers was directed through waveguides in order to be
Fig. 9 An OFRR or a liquid core optical ring resonator (LCORR). WGM
mode is supported within the circular cross section of the OFFR and
evanescent sensing of the target ssDNAs occurs within the probe
ssDNAs conjugated onto the hollow core during sample flow.72
Adapted from ref. 36 with permission.
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coupled to the microrings, and the resonance wavelength
shift data was gathered from output optical couplers. To
functionalise the surface, covalent conjugation of hexynyl ter-
minated ssDNA probes to ABCR modified microrings was
achieved via a click chemistry reaction. Detection of pathogen
Francisella tularensis related dsDNA was done with the micro-
rings having F. tularensis forward primers.
Fig. 11b shows responses of the microrings to different
analyte concentrations due to hybridisation of 25-mer ssDNA
targets. Two representative microrings showed significant re-
sponses to the target ssDNA infusion. The functionalised
microring (blue data) for a specific ssDNA detection revealed
significant wavelength shifts while the control microring (red
data), functionalised with a poly30T back filler, showed re-
sponses only in the order of background noise to varied con-
centrations of the ssDNA target solution. Also, the biosensor
showed no significant response to unspecific ssDNA targets,
proving the ability of the biosensor in terms of selectivity.
Withal, the method suggested a rapid DNA amplification
time (40 min) with a low LOD (2 fg μl−1) level while the LODs
in the standard RPA and the conventional/real-time PCR tech-
niques were reported in the order of pg μl−1 levels.38,39
Y. Shin and co-workers39 suggested a label-free,
multiplexed DNA amplification platform with faster times
(20–30 min) as compared to the above study. In order to de-
tect single point mutations in the Harvey RAS (HRAS) gene,
they fabricated an isothermal solid-phase amplification/de-
tection (ISAD) device consisting of APTES/GAD chemistry ap-
plied microrings. The LOD was reported as 500 fg μl−1 for
this study.
2.3 Detecting methylated DNA and its oxidised derivative
DNA methylation is an epigenetic modification which results
in a 5-methylcytosine (5mC) molecule via covalent modifica-
tion of the fifth carbon in the DNA base cytosine
(Fig. 12a and b).78 The DNA methylation can be presented in
CG, CHG and CHH sequences where H can be A, T or C.79
Without any sequence change, via a chemical modification,
DNA methylation can alter the function of the DNA molecule.
For instance, it has been revealed that DNA methylation plays
essential roles in various cellular processes80 such as develop-
ment and regulation in gene expression (i.e., gene silencing
in eukaryotic cells).79,81–84 Expectedly, abnormal methylation
processes occurring in the chemical structure of the DNA
molecule have a relationship with numerous diseases.80,85
Recent studies have also shown that oxidation of the 5mCs
by enzymes like human ten-eleven translocation 1 (TET1)86
leads to 5mC derivatives such as 5-hydroxymethylcytosine
(5hmC) which was first found in mammalian genomic DNA87
in 1972.88 Like the 5mCs, the 5hmCs are also known to be in-
volved in embryonic development as well as many diseases.84
Additionally, methylated DNA molecules are also known as
biomarkers for cancer.89
Bisulfite sequencing is the most widely used method for
analysing DNA methylation by converting non-methylated cy-
tosines to uracils selectively while keeping methylated cyto-
sines unchanged.42,90,91 Among techniques based on bisulfite
conversion for methylated DNA detection, methylation-
specific (MS) PCR92 is the most commonly used method.41
Despite the fact that MS PCR is widely used, alternative
Fig. 11 The SP-RPA of DNA using label-free microring arrays. (a)
Schematic drawing of the biosensor chip having arrays of microrings
(8 columns of 4 pairs). (b) Real-time, relative wavelength shifts (nm)
due to hybridisation of 25-mer ssDNA at different concentrations (blue
data) and the sensor response of the reference microrings (red data).
The magnitudes of initial transient slopes are given in nm min−1, indi-
cated with an arrow. The decay in the wavelength shifts was observed
due to regeneration of the probes. Adapted from ref. 38 with
permission.
Fig. 10 The RPA process in the solid phase. The recombinase proteins
form a complex between forward/reverse primers and the template
dsDNA (1), the recombinase proteins scan the dsDNA for cognate sites
(2), strand displacement occurs while the structures are stabilised by
ssDNA binding proteins (3), and DNA amplification is done by
polymerase ((4) and (5)). Adapted from ref. 38 with permission.
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detection techniques have also been suggested due to the
complexity and long analysis time of the MS PCR.41,42 For in-
stance, Y. Shin and co-workers40 showed the detection of
DNA methylation biomarkers, RARβ (Retinoic acid receptor
β),93–95 DAPK (Death-associated protein kinase)96,97 and E-
cadherin (epithelial cadherin)93,98 genes since their included
DNA methylation patterns are well known in human cancer
including bladder cancer. Microring arrays, each containing
4 rings (3 measurement rings and 1 reference ring to control
thermal drifts), were fabricated for this purpose. Probes hav-
ing either methylated cytosine or unmethylated thymine were
covalently conjugated to APTES/GAD chemistry applied
microrings. Using the surface modified microresonators pro-
vided real-time analysis and discrimination of methylated
and unmethylated DNA targets following the bisulfite conver-
sion of the targets. However, as the authors also indicated,
for such an approach, a compact biosensor chip having
microfluidic channels and sequential process steps were re-
quired to reduce the process time.
Later on, J. Yoon and co-workers41 suggested a practical
on-chip platform to analyse the methylation status of DNA in
real time based on the former approach.40 Fig. 13a shows the
fabricated biosensor chip consisting of a pre-processing mod-
ule for the bisulfite conversion (red micro-channels) and a
detection module for analysis of the DNA methylation (blue
micro-channels). The methylation status of DNA, obtained
from a cancer-related epithelial cell line (RARβ93–95 gene as a
common human DNA methylation biomarker), was detected
by methyl-specific or unmethyl-specific primers conjugated to
biosensor chips following the bisulfite conversion of the DNA
targets (Fig. 13b). The suggested idea provided amplification
of the methylated DNA strands and specific detection down
to 0% in terms of target concentration (Fig. 13c, blue data
varying from light to dark blue) in a mixture containing
methylated and unmethylated DNA strands. The response of
the biosensor system showed a significant non-specific reso-
nant wavelength shift, probably due to relatively poor dis-
crimination of the used DNA probes against the targets.
As a similar approach to the former work,41 T. Y. Lee and
co-workers42 developed a flexible and on-chip biosensing
Fig. 13 On-chip device for real-time DNA methylation analysis. (a)
Fabricated biosensor chip having a pre-processing chamber for bisul-
fite conversion (red micro-channels) and a detection chamber for the
DNA methylation analysis (blue micro-channels) with three inlets (I, II
and III) and an outlet (IV). (b) Detection of target DNA strands with
methyl-specific or unmethyl-specific primer probe having microrings.
(c) Response of the biosensor to the methylated DNA targets in differ-
ent percentages ranging from 0% to 100% (data from light to dark
blue). Also, the response of the biosensor having unmethyl-specific
probes is given as a negative control (*100%). Adapted from ref. 41
with permission.
Fig. 12 Chemical modification of a DNA molecule by methylation via
cytosines. (a) The illustrative image shows the crystal structure of a
methylated DNA double helix (with sequence ACCGCCGGCGCC) at
two reciprocal central cytosines (illustrated by Christoph Bock, Max
Planck Institute for Computer Science, Computational Biology and
Applied Algorithmics). (b) Chemical structures of the cytosine,
methylcytosine and hdroxymethylcytosine molecules.
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platform for detection of the methylation status of the
RARβ93–95 or HAAO (3-hydroxyanthranilate-3,4-dioxygenase)99
genes as other cancer biomarkers within 65 min. In this
work, instead of the bisulfite conversion, methylation specific
endonuclease digestion100 was used. Additionally, the fabri-
cated biosensor chip consisted of two parts: a modification
module in which cleavage of the appropriate sequence sites
(CCGG) by the enzymes occurred, and a detection module to
understand the methylation status of the targets.
In order to detect the oxidised derivative (5hmC) of the
5mC molecule, R. M. Hawk and co-workers43 used micro-
toroids (Fig. 14a) for selective detection of 5mC and 5hmC
molecules. In this regard, the anti-5hmCs were covalently
conjugated to a GPTMS-coated microtoroid. The measure-
ments were taken in a sample chamber having a microtoroid
and a tapered silica fibre (765 nm) in 100 μl ofphosphate
buffered saline as the measurement solution. Fig. 14b shows
the biosensor response to 50 μl min−1 injection of different
oligonucleotide targets in varying concentrations. As shown
in Fig. 14b, a significant WGM shift was observed due to the
5hmC infusion while lower shifts were also observed in un-
methylated cytosine (C) and the 5mC infusions due to possi-
ble non-specific binding interactions between the biosensor
surface and the targets. The LOD for this study was reported
as 4.2 × 10−13 M with a detection of the 5hmC signal, which
was twice that of the 5mC signal.
The OFRRs are also functional platforms for DNA methyla-
tion analyses because they provide fluidic integrations. J. D.
Suter and co-workers44 used methyl binding protein (MBD-2)
and 5-methylcytidine antibody as probe molecules to detect
artificially methylated ssDNA and dsDNA molecules by
OFRRs coupled to tapered fibres (1550 nm). Either the MBD-2
or the anti-5-methylcytidine probes was covalently conjugated
to a 3-APS-coated inner biosensor surface via DNA as a bi-
functional linker. The suggested system was able to discrimi-
nate methylated and unmethylated DNA strands. They also
reported strong binding affinities of dsDNA and ssDNA to
the MBD-2 and the 5-methylcytidine antibody, respectively.
2.4 Detecting peptide nucleic acid (PNA)
PNAs are artificially synthesized oligomers of peptides which
have backbones analogous to the ones that nucleic acids
have.101,102 The PNAs are more resilient than the DNA probes
towards degradation by enzymes, and they can be modified in
order to capture DNA strands with high specificity and affinity.
In a recent work of G. A. Rodriguez and co-workers,45
interaction between the PNAs and the DNAs was exploited
using porous silicon (PSi) ring resonators in the biosensing
applications. The fabricated Psi ring resonator coupled to its
linear waveguide is shown in Fig. 15a. The PSi ring resona-
tors enable a larger area of interaction for the target mole-
cules with the sensor surface compared to the surface area
limited detection using other types of sensors. The Psi struc-
ture was obtained via controlled electrochemical etching of
silicon, and a refractive index alteration was created by par-
tial thermal oxidation.
The whole surface of the PSi ring resonator was modified
with APTES molecules and SPDP was used as a crosslinker to
conjugate DNA probes for capturing target PNAs. As shown
in Fig. 15b, WGM shifts were observed due to sequential at-
tachment of the probe DNAs (100 μM) and target PNAs (500
nM) to the SPDP-modified PSi ring resonator surface. The
probe DNA attachment to the SPDP-modified ring resonator
surface caused a significant WGM shift due to the high probe
concentration used. In addition, target PNAs hybridised with
the probe DNAs led to an observable WGM shift of 11.10 nm.
Moreover, the Q factor of the fabricated PSi ring resona-
tors in the buffer was reported to have an order of magnitude
of 10,4 while it was one order of magnitude higher in air.
This is partially related to the wavelength of the laser (∼1550
nm) used in this work, at which water absorption29 in aque-
ous media cannot be neglected. Still, the authors reported
that the sensitivity for PNA was 3 nM as calculated by 3σ
analysis, while directly measured lower concentration was
reported as 42 nM. Overall, the authors suggested that the
sensitivity of porous silicon microrings could be engineered
to be higher than that of the conventional silicon microrings.
On the other hand, there are examples of the opposite case,
where silicon microrings were shown to have similar
Fig. 14 Detection of the 5mC and 5hmC molecules using 5hmC
antibody (anti-5hmCs) conjugated microtoroids. (a) Scanning electron
micrograph of a fabricated microtoroid. (b) The response of the
biosensor to buffer, unmethylated (C), methylated (5mC) and
hydroxymethylated (5hmC) cytosine solutions in varying
concentrations (from 1 fM to 1 nM) using a tuneable laser centred at
765 nm. Adapted from ref. 43 with permission.
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sensitivities towards oligonucleotides as well, as already men-
tioned in this review.33,46
3. Detection of ribonucleic acid (RNA)
3.1 Multiplexed microRNA (miRNA) detection and quantification
miRNA, which is a small RNA molecule (containing 19–24
nucleotides46) that does not encode proteins,103 had been
first identified as lin-4 (ref. 104) in 1993. However, the func-
tion of the miRNAs as regulators was discovered in the early
2000s.105–107 These tiny RNA molecules, since then, have been
known to possess transcriptional and post-transcriptional roles
in gene expression.108 The discovery of the regulatory function
of the miRNAs has led the way to gathering further knowledge
on their roles in biological processes. For instance, miRNAs
are known to play profound roles in cellular processes (such
as proliferation,109 apoptosis110 and development111). Addi-
tionally, they also take part in various diseases such as can-
cer,112 diabetes,113 and cardiovascular,114 autoimmune115 and
neurodegenerative116 diseases. Thus, they are excellent bio-
markers for the early detection, diagnosis and prognosis of a
disease. Increased or decreased levels of miRNAs in cells can
be indicators of many diseases.117 Conventional techniques
for miRNA detection can be listed as cloning,118 Northern blot-
ting,119 reverse transcription polymerase chain reaction
(RT-PCR)120 and microarray120,121 analyses. However, many of
these techniques require a large amount of samples46 and suf-
fer from complexities.47,122 F. Porichis and co-workers,123 dem-
onstrated miRNA detection using fluorescence in situ
hybridisation (FISH) technique combined with flow cytometry.
Recently, among label-free techniques,124 electrical detection
techniques125 based on detecting a change in current due to
hybridisation between miRNA and probe, and optical detec-
tion techniques125 (label, label-free, spectroscopy and refrac-
tive index based) have been suggested to increase the sensitiv-
ity of the miRNA detection.
Among optical techniques, the detection of miRNAs using
on-chip integrated microring optical resonators provides
rapid, robust and multiplexed detections126 with considerably
high miRNA sensitivities.
There are two noteworthy examples46,47 of miRNA detec-
tion which used microring optical resonators. A. J. Qavi and
R. C. Bailey46 reported a multiplexed miRNA detection plat-
form using silicon photonic microring resonators. For this
purpose, they fabricated sensor chips each containing 32 in-
dividual microrings including reference microrings having 30
μm diameter with its adjacent linear waveguide (Fig. 4a). This
biosensing platform possessing multiple microrings with sev-
eral unmodified microrings, which serve as references, is
quite advantageous in terms of data corrections for undesired
non-specific interactions and shifts due to thermal and in-
strumental fluctuations. For surface modification, the sensor
chips were exposed to S-HyNic solution following APTES solu-
tion. ssDNA probes (22-mer nucleotides), which reacted with
the S-4FB heterobifunctional crosslinker previously, were con-
jugated covalently to the modified sensor chip surface. A
tuneable laser, centred at 1560 nm, was coupled to the linear,
on-chip waveguides and a resonance wavelength was tracked.
Target miRNA infusions to the sensor chips were performed
in microfluidic flow channels.
Fig. 16b shows a schematic demonstration of hybridisation
between target miRNAs (red) and probe ssDNAs (black) which
leads to a significant shift (Δpm) in the tracked resonance
wavelength. The applicability of the sensor chips to a
multiplexed miRNA analysis is demonstrated in Fig. 16c. Four
sets of microrings were functionalised with four different fully
complementary ssDNA probes, individually. Each modified
microring showed a dramatic response to its corresponding
target miRNA during the sequential introduction of brain can-
cer relevant miRNA targets (miR-133b, miR-21, miR-24-1 and
let-7c) through the microfluidic system. Although the miRNA
targets had the same length (22-mer nucleotides), variations
in the resonance shifts that were observed as they hybridised
with their complete counterparts on the biosensor surface
(Fig. 16c) remained as an unaddressed issue. In this study, a
detection limit of 150 fmol of miRNA was reported and the
suggested biosensing mechanism provided a multiplexed
quantification of the 4 aforementioned miRNAs. Moreover, an
isothermal method was suggested to discriminate single base
Fig. 15 The PSi ring resonator for biosensing applications. (a) An SEM
image of the Psi ring resonator (left) with a zoomed image showing
the porous structure (right). The porosity was attained by
electrochemical methods, while a higher refractive index on the
waveguide part was fabricated using thermal oxidation. The oxidised
part was then further functionalised. (b) Shifts of the WGMs in the
transmission spectra due to sequential attachment of the probe DNAs
and the target PNAs to the SPDP functionalised PSi ring resonator.
Adapted from ref. 45 with permission.
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differences by performing hybridisation in 50% v/v formam-
ide solution. Since detecting single base pair variations in an
oligonucleotide is a challenging task, the demonstrated
miRNA biosensing platform suggests a highly sensitive and
selective miRNA detection approach.
Another example of the multiplexed detection of miRNA is
the other work of A. J. Qavi and co-workers.47 They fabricated
sensor substrates each containing 32 addressable microring
resonators in the same manner as that in the previous
works33,46,126 and S-4FB modified ssDNA probes (22-mer nu-
cleotides) were covalently conjugated to Hy-Nic silane-coated
sensor substrates. An external cavity laser was used to trace
the resonance wavelength. They fabricated laser etched
microfluidic channels for analyte infusion.
Fig. 17a shows their miRNA sensing approach in this
work. Target miRNAs were infused, using a peristaltic pump,
through the microring having fully complementary ssDNAs.
Subsequently, antibody S9.6 (anti-DNA) was harvested from a
mouse hybridoma cell line that was able to recognise the
formed DNA–RNA heteroduplexes on the surface and was in-
troduced to the system following blocking of the microring
surface to avoid non-specific interactions. As shown in
Fig. 17b, resonance wavelength shifts (Δpm) for 3 separate
microrings were observed after anti-DNA infusion following
target miRNA infusion. Since anti-DNA binding response was
higher than that of the bound miRNAs to the surface, the sys-
tem provided an enhanced miRNA detection limit down to
350 amol (10 pM), which is lower than the detection limit
reported in the previous study.46
In order to investigate antibody (S9.6) binding kinetics,
antibody solutions having the same concentration (2 μg ml−1)
were infused to the microrings with varied capture probe
Fig. 16 Label-free and multiplexed detection of miRNAs. (a) Scanning
electron micrograph of a microring with its linear waveguide (indicated
with an arrow), (b) schematic drawing showing target miRNAs (red)
captured by ssDNA probes (black) and (c) specific detection using four
different miRNAs (miR-133b, miR-21, miR-24-1 and let-7c) on a single
chip containing four sets of microrings, each functionalized with dif-
ferent ssDNA probes. In between each miRNA infusion, phosphate
buffered saline solution was introduced to the system. Adapted from
ref. 46 with permission.
Fig. 17 Increasing sensitivity in silicon photonic microring resonators
using antibodies. (a) Schematic drawing showing DNA probe modified
microring exposed to target miRNA and antibody (S9.6) sequentially.
(b) Resonance wavelength shifts (Δpm) from 3 separate microrings due
to target miRNA (miR-24-1) and antibody (S9.6) infusion sequentially.
(c) Responses of antibody (2 μg ml−1 S9.6) binding to the microrings
having varied capture probe concentrations (from 16 nM to 20 μM)
while the target miRNA concentrations were kept constant. (d) Data
show the applicability of the suggested mechanism to multiplexed
miRNA analysis. 2 target DNA functionalised chips were exposed to
antibody solution following target infusion (miR-16 and miR-21). Only
those having their complementary probe DNA and target miRNA
showed a dramatic response due to the antibody infusion. Adapted
from ref. 47 with permission.
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densities following the miRNA infusions at the same concen-
tration (40 nM). As shown in Fig. 17c, the elicited response
due to antibody binding increased as the surface probe den-
sity increased. On the other hand, as the authors also indi-
cated, after a certain surface probe density this increasing be-
haviour was not observed since possibly occurring steric
effects due to probe crowding on the resonator surface
resulted in a decrease in the antibody-binding rate.
Fig. 17d shows a multiplexed platform using this miRNA
sensing approach. 2 different sensor arrays (Fig. 17d,
each column) were infused by only 1 target miRNA-
containing solution and only the microrings having DNA–
RNA heteroduplexes elicited a response to the S9.6 infusion.
The presented study demonstrates a simple miRNA sensing
platform, which enabled real-time and multiple read-out
measurements.
3.2 Messenger RNA (mRNA) detection
mRNA is a single-stranded RNA intermediate (between 500
and 10 000 bases), which possesses the complementary se-
quence of a DNA strand for representing a protein during the
transcription process.127 Studies have revealed a relationship
between some mRNA expression levels (or mRNA abundance)
and diseases,128 e.g. in cancer types like colorectal,129 pros-
tate,130 breast131 and liver diseases.132 Hence, as one of the
transcriptomic biomarkers, detection of the mRNA molecules
is quite critical for the diagnosis, treatment and determina-
tion of the stage of different types of diseases.133–136
So far, bulk mRNA detection has commonly been done via
microarray137–139 and real-time reverse transcription PCR
(RT-PCR)140,141 analyses. Also, a label-free cantilever-array
sensor142 was suggested as an mRNA detection platform.
However, to detect cell-to-cell mRNA variations,143 which can
be observed in heterogeneous diseases like cancer, nano-
flares144 and core–shell nanocomposites135 were used rather
than the aforementioned bulk mRNA detection techniques,
which were reported to be incapable of detecting the alter-
ations.135,144 In fixed or living cells, the mRNA levels were
obtained using molecular beacons.145,146 Withal, imaging of
individual mRNA molecules in fixed cells was achieved using
labelled probes.147 In another study,123 at the single cell level
mRNA detection, the FISH technique combined with flow cy-
tometry was used. Also, electrochemical-based biodetection
techniques148–151 can be used for the mRNA detection.
Several optical biodetection152,153 techniques can provide
rapid and label-free quantification of the mRNA molecules.
As an optical detection technique, J. T. Kindt and co-
workers48 suggested silicon photonic microrings as optical
microresonators for full-length mRNA quantification in a
multiplexed manner with a 512 amol limit of mRNA detec-
tion. Likewise in previous works,33,46,47 the S-4FB modified
ssDNAs as probe molecules were tethered to the microring
surface covalently. Also, the resonance wavelength shift was
enhanced by adding short DNA chaperones and
submicrometer beads, which improve hybridisation kinetics
between the ssDNA probes and the target mRNA molecules.
3.3 Transfer messenger RNA (tmRNA) detection
tmRNA, which is a small molecule encoded by the ssrA
gene155 but is different from transfer RNA (tRNA) and ribo-
somal RNA (rRNA), was discovered in 1978 (ref. 154) as a new
RNA component. This stable RNA piece can be found in
many bacteria with a high copy number per cell, Escherichia
coli being the most common example.156–158 In all eubacteria
and some eukaryotic organelles, tmRNAs play critical roles in
translational surveillance and ribosome rescue to maintain
the protein synthesis capacity of a cell.157,159 The tmRNAs
can be used as biomarkers in order to differentiate between
bacterial species and genus, since each bacterial strain is
known to contain unique regions of sequence.49,158 Addition-
ally, viable bacterial populations can be distinguished from
non-viable ones using these biomarkers.49,160
Thus far, the tmRNA molecules were used as targets in
conventional techniques for several detection purposes such
as bacterial identification158 or observing tmRNA localisation
in bacteria161 via fluorescence in situ hybridisation technique,
and for pathogen detection using techniques based on
nucleic acid sequence-based amplification,162,163 real-time
PCR,155 real-time reverse transcription PCR (RT-PCR)164 or
surface plasmon resonance.165
Using photonic microcavities for tmRNA detection, O.
Scheler and co-workers49 discriminated the tmRNAs for differ-
ent bacterial species. For this purpose, they fabricated chips
having 32 individually addressed microrings integrated with a
microfluidic assembly. An aryl aldehyde moiety having probes
related to either S. pneumoniae or S. agalactiae bacteria was co-
valently conjugated to a reactive hydrazine group having
microrings via hydrazone bonding. The fragmented tmRNA
molecules were specifically detected via hybridisation with
their probe DNA counterparts (Fig. 18a). However, in this tech-
nique, the detection of the tmRNA molecules required a pre-
processing of the tmRNA samples via thermal tmRNA denatur-
ation with/without a 10-fold excess of chaperones or by chemi-
cal tmRNA fragmentation, by which the secondary structures
of the tmRNA molecules are disrupted. The obtained WGM
shifts (pm) due to the sequential flow of different tmRNAs be-
longing to 4 bacteria, K. pneumoniae, E. faecium, S. agalactiae,
and S. pneumoniae, are shown (Fig. 18b). The LOD obtained
for this study was reported as 53 fmol S. pneumoniae tmRNA,
which corresponds to approximately 3.16 × 107 CFU of bacteria.
Although the suggested approach provided rapid and spe-
cific detections of different tmRNA species, as the authors also
adverted to, the results showed a difference in terms of the
WGM shift magnitudes, which was possibly observed due to
undesired residual secondary structures of the tmRNA targets
following the pre-process.
4. Protein detection using aptamers
and DNA–antibody conjugates
The use of aptamers instead of antibodies is a recent ap-
proach in optical microresonator-based biosensing. The











































Lab Chip, 2016, 16, 2572–2595 | 2587This journal is © The Royal Society of Chemistry 2016
aptamers specifically recognise molecular patterns with high
affinity. The main difference of the aptamers from protein-
based antibodies is that they consist of nucleotides rather
than amino acid chains, and they are synthesised artificially
instead of being produced within living organisms.166 Al-
though they have more simple primary structures, i.e. smaller
dimensions in terms of length and molecular weight,167 the
aptamers have successfully been demonstrated to have con-
siderable affinity towards their targets, which are mostly pro-
teins. Besides, they are more stable than their protein coun-
terparts in terms of alterations in their environment and
shelf life.168 Their attachment to a silicon/silica surface is
practically the same as in the oligonucleotide attachment
strategies, which are well known,169 and relatively easier than
covalent binding of the antibodies. All the aforementioned
factors make aptamers convenient for probing biological enti-
ties. Yet, their use in optical microresonator-based bio-
detection is not abundant. Although being quite promising,
there are only a handful of examples regarding their use in
this field. In our opinion, the rare use of the aptamers in op-
tical microresonator-based biosensing is likely due to the
possible difficulties encountered during the optical measure-
ments, rather than the aptamers themselves, which was
discussed previously within the text.
The earliest example related to optical aptasensors dates
back to 2006, where Zhu and co-workers50 demonstrated
human thrombin detection using aptamer-conjugated
microspheres.
The experimental set-up used in this work is shown in
Fig. 19a. A fibre prism was used to couple light from a 980
nm tuneable laser source to a microsphere, while the laser
was controlled via a computer DAQ card. They used 3-APS
molecules to coat the microsphere surface via vapour deposi-
tion, and PDC as homobifunctional crosslinker to covalently
attach amine-modified aptamers. The spectral response of
the modified optical microsphere to the increased concentra-
tions of thrombin (from 50 nM to 4.34 M) is given in
Fig. 19b. Each increased spectral response showed a binding
event that occurred between the aptamer and thrombin con-
jugates. However, after injection of 3.2 M thrombin, slower
responses were obtained, most probably due to almost com-
plete probe saturation on the microsphere surface caused by
the infused high target concentration. They also reported a
sensitivity of 1 NIH unit per ml, which corresponded to a
concentration of 10 nM, limited by their spectral resolution
of 0.2 pm. The corresponding data are shown in Fig. 19c.
The upper limit for a measurable dynamic range was
reported as 5 μM. Yet, specificity seriously limited this dy-
namic range, particularly for thrombin, since the thrombin,
with concentrations which were higher than 100 nM, was
Fig. 18 Detecting different tmRNA species on a single chip with
microrings integrated to a microfluidic assembly. (a) Schematic
drawing shows their tmRNA detection approach in this work: the
fragmented tmRNAs were hybridised with their probe counterparts
attached to the microring surface. (b) Different tmRNAs from 4
bacteria, Klebsiella pneumoniae, Enterococcus faecium, Streptococcus
agalactiae, and Streptococcus pneumoniae, were introduced
sequentially to the flow chamber. Relative shifts (Δpm) from repeated
experiments were obtained due to probe–target tmRNA hybridisation.
Black and red data show response of the microrings having S.
pneumoniae and S. agalactiae tmRNA specific DNA probes,
respectively. In between each target infusion, washing with neat buffer
solution was done. Adapted from ref. 49 with permission.
Fig. 19 Thrombin detection using an aptamer conjugated
microsphere. (a) Experimental set-up (left). In a fluidic cell, the light
from a tuneable diode laser (980 nm) is coupled to the microsphere
via a fibre prism coupler (right). The laser was controlled using a com-
puter data acquisition (DAQ) card. (b) Increasing concentrations of
thrombin were applied and the WGM shifts (pm) were observed. The
concentrations were 50 nM, 142 nM, 340 nM, 750 nM, 1.88 M, 2.56 M,
3.2 M, 3.786 M, and 4.34 M, beginning from the second arrow from
the left. (c) The WGM shift (pm) regarding the thrombin concentration
(NIH per ml) is given. 1 NIH unit corresponds to 10 nM. Adapted from
ref. 50 with permission.
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described as interacting with irrelevant aptamer probes. An
arising electrostatic effect can be one of the reasons for
such undesired interactions. Considering the fact that the
isoelectric point of thrombin is high and thrombin is a cat-
ion at the pH of blood,170 performing the experiment at pH
∼7 can contribute to undesired interactions between the
thrombin proteins and the irrelevant aptamers. The percent-
age of specific to non-specific binding interactions was cal-
culated as 20% in concentrations higher than 500 nM (in
phosphate buffered saline at pH 7.4). Moreover, the demon-
strated substantial resistance of the aptamer-conjugated
microspheres towards the BSA proteins could be another
evidence of the aforementioned electrostatic effects. Also,
considering the pH (∼7) of the thrombin experiments, BSA
is a quite suitable protein for investigating non-specific in-
teractions occurring on a surface, since albumins are the
most abundant proteins in blood. In addition, the BSA is
negatively charged under the given experimental conditions,
and since the aptamers also have a net negative charge, the
occurring electrostatic repulsion can provide anti-fouling
characteristics to the optical aptasensors.
Moreover, the optical coupling set-up used in this research
utilises a fibre probe which was polished to form a prism at
its end. This prism was used to couple light evanescently to
the optical resonator. Although integration of high-Q factor
microresonators like the microspheres with microfluidic sys-
tems is relatively challenging, this strategy can be further de-
veloped towards attaining this aim, resulting in a huge leap
towards ultrasensitive optical biosensors integrated with lab-
on-a-chip technologies.
A more recent example of the use of aptamers in combina-
tion with optical microresonators is the work of Park and co-
workers.51 Their detection scheme using anti-IgE aptamers is
given in Fig. 20a. They performed multiplexed detection of
IgE and human thrombin using APTES/GAD chemistry ap-
plied microring resonators having covalently attached
aptamers. The detection limits reported for the IgE and hu-
man thrombin were 33 pM and 1.4 nM, respectively. The
selectivity towards IgE was higher probably due to its larger
dimensions. For a multiplexed detection, the optical micro-
rings were functionalised individually.
Fig. 20b and c show the spectral shifts (pm) and the bind-
ing curve obtained at increasing IgE concentrations (from 67
pM to 0.67 nM), respectively. As can be concluded from
Fig. 20b and c, the anti-IgE aptamer conjugated microrings
showed considerable selectivity towards the IgE protein and
similar responses with/without the presence of BSA proteins.
The microrings functionalised to detect the thrombin pro-
teins also showed resistance to the BSA molecules, likewise
reported in the above work.50 The dynamic range of the bio-
detection was given within a 4 orders of magnitude concen-
tration difference. It was also mentioned by the authors that
the biosensor could be reusable at least 10 times, using di-
luted sodium hydroxyl (NaOH) solution. In addition, a dis-
tinct advantage of using such a system is its suitability for
microfluidic integration. In our opinion, this study is a fron-
tier example of optical aptasensors, which have a potential to
be developed especially for point-of-care applications.
The last example regarding the optical aptasensors is the
work of Pasquardini and co-workers52 describing protein de-
tections in complex media (human serum). They were able to
detect thrombin concentrations less than 66 nM. The
MPTMS-coated microspheres were functionalised with thio-
lated anti-thrombin aptamers (TBA) via disulfide chemistry.
Light (773 nm) was coupled to the microresonator using a
Fig. 20 Human immunoglobulin E (IgE) protein detection using
optical microring aptasensors. (a) Once the aptamers are covalently
attached to an optical microresonator surface, they can be stored for
longer times compared to that of their antibody counterparts. The
result of biorecognition is observed as a WGM shift (Δλ). Particularly, all
on-chip systems, such as microring resonators coupled to their wave-
guides, can considerably benefit from the aptamers. (b) The spectral
responses of anti-IgE aptamer conjugated microring resonators to in-
jections of varied IgE concentrations (from 67 pM to 0.67 nM) and 15
μM bovine serum albumin (BSA) as control. (c) The binding curve for
the varied IgE concentrations (nM). Black squares, green triangles and
red circles show the results obtained by adding IgE solution continu-
ously, one certain IgE concentration at a time in the presence of BSA
and one at a time without the BSA, respectively. Adapted from ref. 51
with permission.
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tapered optical fibre. Fig. 21a shows the Q factors in air
obtained from a microsphere after each surface modification
step: cleaning (black line), MPTMS coating (red line) and co-
valent binding of the thrombins following TBA-15 aptamer
probe conjugation (blue line). As can be seen from Fig. 21a,
broadening in the spectral linewidth of the WGM was ob-
served after each surface modification step due to a gradual
increase in surface roughness of the microsphere, which is
commonly encountered in surface modification of optical
microresonators.
The inset in Fig. 21b shows confocal microscopy images
of fluorescein (FAM) dye labelled TBA-15 (FAM-TBA-15)
probes on a microsphere (green) and bound rhodamine dye
labelled thrombins (red) on a TBA-15 probe conjugated
microsphere. The authors showed that the TBA-15 conjugated
optical aptasensor was particularly successful in detection in
diluted human serum. The response of the biosensor towards
thrombin in the diluted human serum (Fig. 21c) was identi-
cal to the response obtained in the buffer solution (Fig. 21b).
Also, the biosensor did not show any response towards the
BSA molecules, maintaining its specificity. The authors also
showed reversible regeneration of the aptamers after bio-
sensing several times. Although a minimum detectable limit
was not provided, it can be deduced from the results to be
less than 10 nM, similar to the above-mentioned work.50
Although there are only a few examples of aptamers re-
garding microresonator-based optical biosensing, they can
be considered as useful probes in this field. However, the
main concern regarding their application is specificity,
which seems to be solved in the aforementioned work52 to
a great extent. Additionally, in all the discussed works, opti-
cal biodetection of the thrombin via aptasensors was
performed. Although various types of aptamers are commer-
cially available, studying the binding interactions between
α-thrombin aptamers and thrombins via optical resonators
is plausible, since they have been frequently used in diverse
optical biodetection studies.171,172 Though still more time is
required for optical aptasensors to be common, there is yet
an unprecedented potential regarding this field waiting to
be explored and exploited. Especially, point of care applica-
tions integrated with microfluidic lab-on-a-chip systems
could benefit from the durability of the aptamer probes
substantially.
Lastly, as distinct from aptamer-based optical biosensing,
A. L. Washburn and co-workers53 suggested an alternative ap-
proach for optical microring-based antigen sensing. To in-
crease the antigen binding capacity of the suggested system,
they fabricated microrings with attached ssDNAs in arrays,
and DNA–antibody conjugates having counterparts of the
probe ssDNAs were hybridised on the microring surface. As
the authors also indicated, using this approach provided
practical DNA-based microring arrays for protein detection,
which can be considered as more robust than only antibody-
based ones in terms of stability and long-term durability un-
der appropriate storage conditions. Additionally, the DNA–
antibody conjugates offered self-assembled antibody arrays
(Fig. 22a) with a reduced steric hindrance, which plays a vital
role in enhancing the antigen binding kinetics.34,173,174
Fig. 22b shows the slopes of spectral responses (Δpm) aris-
ing from 1 μg ml−1 prostate specific antigen (PSA) binding
onto the modified microring surface using the DNA–antibody
conjugates (F′-anti-PSA-5A6s, black squares) and antibodies
Fig. 21 Aptamer-based optical biosensing using microspheres in
diluted human serum. (a) Measured Q factors (at 773 nm) of a bare
(black line), the MPTMS-coated (red line) and the TBA-15 probe–
thrombin conjugate (blue line) microsphere, respectively. (b) The re-
sponse (GHz) of the TBA-15 conjugated microsphere towards thrombin
in buffer is identical to (c) the response (GHz) in diluted human serum.
This shows the biosensing capability of the aptasensor in a complex
medium. Inset: Confocal microscopy images of the FAM-TBA-15
probes (green) and the rhodamine dye labelled thrombins (red) on a
microsphere. Adapted from ref. 52 with permission.
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(anti-PSA-5A6s, red circles). The slope obtained by the F′-anti-
PSA-5A6s (0.25) were 2.5 times higher than the slope obtained
by using the anti-PSA-5A6s (0.10), proving the enhanced anti-
gen sensing ability of the suggested antibody conjugation
approach.
Future prospects
In this review, we have discussed various oligonucleotide-
based applications of optical microresonators. All the works
described here have one trait in common: they are all experi-
mental works offering robust, reproducible and multiplexed
detections; however, their implementations are not easily ac-
cessible yet. This does not necessarily mean that the WGM-
type biosensors are inferior to their counterparts such as Sur-
face Plasmon Resonance (SPR) biosensors because SPR-based
biosensing for instance has a history dating back to at least
20 years compared to the WGM-type biosensors. Therefore,
the production development regarding optimisation of the
WGM-type biosensors could be considered as successfully ac-
complished only very recently. Yet, there are still a few major
drawbacks on the side of optical microresonators as biosen-
sors with robust operation. This last section is devoted to
providing the general strategies that can be applied in order
to enhance the applicability of the WGM type biosensors,
anticipating their large-scale applications.
Material constraint is a critical point in biosensor technol-
ogy. Although silicon and silica are relatively cheap materials,
and chip scale production techniques are quite successful,
plastics still constitute a considerably cheaper alternative,
which is more suitable for mass production. A microfabricated
optical microresonator can be utilised to form a mold, which
then can be used to mass produce optical microresonators
from plastics.175 This means considering a new surface chem-
istry for bioconjugation as well, but there already exist versatile
methods for chemically modifying plastics.176
There are also various other geometries of micro-
resonators that have not been used for oligonucleotide-based
biodetection. Microgoblets177 and microbubbles178 are two
outstanding microresonator types that can be exploited for
this purpose. Microgoblets are formed as polymer structures
standing on silicon pillars, similar to microtoroids. They can
be batch produced, and they can be used as microlasers by
incorporating fluorescent molecules in their polymer. Laser
is pumped by free space coupling, which is comparably easier
than evanescent coupling, and the shift in the lasing wave-
length could be monitored for biosensing.177 Microbubbles,
on the other hand, are structures similar to the OFFR resona-
tors, but light is coupled to a bubble formed by arc discharge
on the glass capillary. This enhances the Q factor by forming
a trap for the travelling light. They could be functionalised in
a manner similar to that of the OFFRs.178
Optical coupling of the WGM-type biosensors remain one
of the greatest challenges. On-chip coupling of microtoroids28
has been previously demonstrated in various studies and also
described within this text. More robust methods for on-chip
coupling of particularly the STIMs are quite critical regarding
this aspect. This would enable an easy microfluidic integra-
tion, greatly enhancing the applicability of these biosensors.
Fig. 22 Self-assembled DNA–antibody conjugates in microring arrays
for prostate specific antigen (PSA) detection. (a) Schematic drawing
showing how probe ssDNAs (red, blue and green strands) previously
spotted on the microrings form DNA duplexes with the corresponding
DNA–antibody conjugates, which have their counterparts. (b) The
graph shows the increase (from 0.10 to 0.25) in the slope of the
relative shift (Δpm) in the presence of the antibody–DNA conjugates.
The PSA antigen (1 μg ml−1) binding towards the DNA–antibody
conjugates (F′-anti-PSA-5A6s, black squares) is 2.5 times greater than
the result obtained by covalently bound surface antibodies (anti-PSA-
5A6s, red circles). Adapted from ref. 53 with permission.
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Fig. 23 compares the challenges and potential/current ap-
plications of WGM optical microcavities. One serious prob-
lem related to optical biosensing using WGM micro-
resonators is the expensive machinery behind it. Especially,
tuneable lasers are costly research tools, and the whole sys-
tem requires to be elaborately engineered during construc-
tion, operation, and maintenance. While current technology
enables observation of extremely sharp resonances, tracking
them for ultimate sensitivity also requires sensitive, thus ex-
pensive, devices. Therefore, a compromise should definitely
be made. Point-of-care applications, for instance, do not nec-
essarily require single molecule sensitivity; yet, increasing the
shifts from the order of picometers towards nanometers
could enable the tuneable lasers to be replaced with generic
laser diodes. The miniaturisation of the system can go fur-
ther if new laser sources can be developed by micro-
resonators themselves. This could be attained by sensitivity
enhancement techniques such as post recognition binding of
bulky moieties,48 or catalytic mass unloading.32 Plasmonic
enhancement could be exploited as well to increase the sensi-
tivity of the microresonator towards perturbations in the me-
dium.23,179 In this way, detection could be performed by
intensity interrogation, in a similar fashion to the SPR mea-
surements by tracking the intensity at a fixed wavelength
around the resonant wavelength180 instead of the spectral
shift, providing high-throughput analyses. On the other
hand, single molecule detection experiments can help scien-
tists to decipher many mysteries of life currently inaccessible
with contemporary techniques. Single molecule binding
events can be observed by using the WGM-type optical micro-
resonators. The WGM biosensors are among the few tools
that enable such a difficult task. For a reliable and reproduc-
ible experimental setup to be devised, the coupling problem
should be seriously solved to a larger extent, enabling
multiplexed detection.
Moreover, WGM resonators can provide various informa-
tion about molecular orientations181 and conformational
changes,182 since they support two orthogonal polarisations:
the TE and TM modes. An electromagnetic wave at a certain
polarisation can cause a shift both in the TE and in the TM
modes since optical anisotropy in the refractive index occurs
due to the preferred direction of self-assembled molecules
adsorbed on the microresonator surface.16 The aforemen-
tioned idea can be utilised to understand orientations and
conformational changes of oligonucleotide molecules, self-
assembled on a WGM resonator surface in a label-free
manner.
Furthermore, surface engineering of the optical micro-
resonators should seriously consider specificity as well as
sensitivity. This applies whether an application is for a point-
of-care detection or a single molecule measurement. There
are recent examples of highly specific detections of oligonu-
cleotides34 as well as proteins.26 Research in this field is
promising when these results are considered.
In summary, optics possesses important possibilities re-
garding increasing the quality of our lives and extending our
knowledge about the nano world. Referring to accurate ques-
tions would probably lead the scientific knowledge towards
unprecedented answers, expanding our horizon.
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